4 results about "High-LET Radiotherapy" patented technology

This disclosure relates to a radiotherapy system, a method for controlling the radiotherapy system, a computing device, and a computer-readable storage medium. In one aspect, the radiotherapy system includes: a radiotherapy apparatus including a source device for emitting therapeutic rays; a guide rail extending through the radiotherapy apparatus; and a shielding door movably disposed on the guide rail for movement between a first position and a second position, wherein, in the first position, the shielding door is located below the source device to shield the therapeutic rays; and in the second position, the shielding door is moved away from below the source device to allow the therapeutic rays to irradiate a radiotherapy space below the source device. This effectively alleviates the target subject's tension, depression, and other emotional states, thereby effectively reducing involuntary movements of the target subject and improving radiotherapy accuracy.

This invention provides an image processing-based radiotherapy method, belonging to the field of medical image processing and radiotherapy technology. This method acquires multi-dimensional data such as the patient's CT images, physiological state information, body mass index, and gender. After preprocessing the CT images, it utilizes a deep convolutional neural network and multimodal feature fusion technology to extract and fuse image features, physiological state features, weight features, and gender features to generate high-quality feature vectors. Furthermore, through semi-supervised learning, combined with labeled and unlabeled CT images, it adaptively adjusts the radiotherapy dosage, thereby achieving precise radiotherapy. This invention, employing the above-mentioned image processing-based radiotherapy method, can effectively improve the personalization and accuracy of radiotherapy planning, and has significant technical application value.

This invention relates to the field of biomedical technology, disclosing a drug combination and its application for improving the sensitivity of FLASH radiotherapy in the treatment of colorectal cancer peritoneal metastases. The combination comprises a therapeutically effective amount of an APOE inhibitor and / or an IL1B agonist. By combining an APOE inhibitor and / or an IL1B agonist, this invention can precisely target and intervene in abnormal gene expression after FLASH radiotherapy, thereby improving the abnormal gene expression state after FLASH radiotherapy, eliminating the negative impact of abnormal gene expression on the efficacy of radiotherapy, significantly improving the therapeutic sensitivity of FLASH radiotherapy to colorectal cancer peritoneal metastases, achieving radiosensitization, and providing a new targeted strategy for the radiotherapy treatment of colorectal cancer peritoneal metastases.

The application belongs to the technical field of radiotherapy, and relates to a monitoring and interaction system for a radiotherapy scene, a model construction method and a medium. The system synchronously collects multi-modal physiological data of a patient through a ring-shaped collection device arranged between a radiotherapy device head and a treatment bed, and realizes linkage control and patient interaction guidance in a radiotherapy process based on multi-source heterogeneous data assimilation, physical constraint digital twin modeling and real-time prediction. A unified technical system of "multi-modal physiological data synchronous collection-multi-source heterogeneous data assimilation-physical constraint digital twin modeling-real-time prediction and linkage control" is constructed, so that real-time mapping, trend prediction and active interaction control of the physiological state of the patient can be realized without interfering with the operation of the radiotherapy device, and the treatment accuracy, safety and patient compliance in the radiotherapy process are improved.